Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Supporting Our Clients for 70 Years with Insurance Technology
Mitchell
Article
Taking a Position on Pre- and Post-Repair Vehicle Scanning
As vehicle complexity has increased exponentially in the last decade, collision repair diagnostics has taken center stage in the collision repair i
Mitchell
Article
The CDC and P&C: New Opioid Guidelines a Powerful Step in the Right Direction
The Centers for Disease Control (CDC) newly established guidelines for the prescribing of opioids for chronic pain.
Mitchell
Article
The Compliance Corner: Opt-Out, an Alternative Workers' Compensation Model
Opt-out in the workers’ compensation world is 2016’s buzzword for deregulation of payment for workers’ compensation claims at the state level.
Mitchell
Article
The Compliance Corner: Telemedicine: New Innovations in the Old Program
Telemedicine is the method of delivering health care electronically through applications like smart phones, email, and skype.
Mitchell
Article
The Compliance Corner: Understanding MACRA in the P&C Industry: Medicare Access and CHIP Reauthorization Act of 2015
A change is in the wind, or more like a tornado, when it comes to new healthcare reforms, particularly on the payment side.